102 related articles for article (PubMed ID: 22517293)
1. Effect of L-arginine and selenium added to a hypocaloric diet enriched with legumes on cardiovascular disease risk factors in women with central obesity: a randomized, double-blind, placebo-controlled trial.
Alizadeh M; Safaeiyan A; Ostadrahimi A; Estakhri R; Daneghian S; Ghaffari A; Gargari BP
Ann Nutr Metab; 2012; 60(2):157-68. PubMed ID: 22517293
[TBL] [Abstract][Full Text] [Related]
2. The effect of hypocaloric diet enriched in legumes with or without L-arginine and selenium on anthropometric measures in central obese women.
Alizadeh M; Daneghian S; Ghaffari A; Ostadrahimi A; Safaeiyan A; Estakhri R; Gargari BP
J Res Med Sci; 2010 Nov; 15(6):331-43. PubMed ID: 21526106
[TBL] [Abstract][Full Text] [Related]
3. The effects of legumes on metabolic features, insulin resistance and hepatic function tests in women with central obesity: a randomized controlled trial.
Alizadeh M; Gharaaghaji R; Gargari BP
Int J Prev Med; 2014 Jun; 5(6):710-20. PubMed ID: 25013690
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients.
Lucotti P; Setola E; Monti LD; Galluccio E; Costa S; Sandoli EP; Fermo I; Rabaiotti G; Gatti R; Piatti P
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E906-12. PubMed ID: 16772327
[TBL] [Abstract][Full Text] [Related]
5. Effect of 3-month L-arginine supplementation on insulin resistance and tumor necrosis factor activity in patients with visceral obesity.
Bogdanski P; Suliburska J; Grabanska K; Musialik K; Cieslewicz A; Skoluda A; Jablecka A
Eur Rev Med Pharmacol Sci; 2012 Jun; 16(6):816-23. PubMed ID: 22913215
[TBL] [Abstract][Full Text] [Related]
6. Effects of Nigella sativa oil with a low-calorie diet on cardiometabolic risk factors in obese women: a randomized controlled clinical trial.
Mahdavi R; Namazi N; Alizadeh M; Farajnia S
Food Funct; 2015 Jun; 6(6):2041-8. PubMed ID: 26029855
[TBL] [Abstract][Full Text] [Related]
7. Effect of a high-calcium energy-reduced diet on abdominal obesity and cardiometabolic risk factors in obese Brazilian subjects.
Torres MR; Francischetti EA; Genelhu V; Sanjuliani AF
Int J Clin Pract; 2010 Jul; 64(8):1076-83. PubMed ID: 20642707
[TBL] [Abstract][Full Text] [Related]
8. Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity.
Kar P; Laight D; Rooprai HK; Shaw KM; Cummings M
Diabet Med; 2009 May; 26(5):526-31. PubMed ID: 19646193
[TBL] [Abstract][Full Text] [Related]
9. High protein diets decrease total and abdominal fat and improve CVD risk profile in overweight and obese men and women with elevated triacylglycerol.
Clifton PM; Bastiaans K; Keogh JB
Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):548-54. PubMed ID: 19179060
[TBL] [Abstract][Full Text] [Related]
10. Effect of 6 months of exercise and isoflavone supplementation on clinical cardiovascular risk factors in obese postmenopausal women: a randomized, double-blind study.
Aubertin-Leheudre M; Lord C; Khalil A; Dionne IJ
Menopause; 2007; 14(4):624-9. PubMed ID: 17290158
[TBL] [Abstract][Full Text] [Related]
11. Effect of orlistat on cardiovascular disease risk in obese adults.
Swinburn BA; Carey D; Hills AP; Hooper M; Marks S; Proietto J; Strauss BJ; Sullivan D; Welborn TA; Caterson ID
Diabetes Obes Metab; 2005 May; 7(3):254-62. PubMed ID: 15811142
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic effects of rosiglitazone in nondiabetic patients with metabolic syndrome.
Aquilante CL; Kosmiski LA; Zineh I; Rome LC; Knutsen SD
Pharmacotherapy; 2010 Mar; 30(3):236-47. PubMed ID: 20180607
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk factors in obese women and their first-degree relatives.
Saraç F; Ozgen AG; Yilmaz C; Tüzün M
Anadolu Kardiyol Derg; 2007 Dec; 7(4):371-7. PubMed ID: 18065331
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial on the effects of legumes on cardiovascular risk factors in women with abdominal obesity.
Safaeiyan A; Pourghassem-Gargari B; Zarrin R; Fereidooni J; Alizadeh M
ARYA Atheroscler; 2015 Mar; 11(2):117-25. PubMed ID: 26405440
[TBL] [Abstract][Full Text] [Related]
15. Body fat distribution and their associations with cardiovascular risk, insulin resistance and β-cell function: are there differences between men and women?
Chen G; Liu C; Chen F; Yao J; Jiang Q; Chen N; Huang H; Liang J; Li L; Lin L
Int J Clin Pract; 2011 May; 65(5):592-601. PubMed ID: 21489083
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of weight loss on a very-low-carbohydrate diet compared with an isocaloric high-carbohydrate diet in abdominally obese subjects.
Tay J; Brinkworth GD; Noakes M; Keogh J; Clifton PM
J Am Coll Cardiol; 2008 Jan; 51(1):59-67. PubMed ID: 18174038
[TBL] [Abstract][Full Text] [Related]
17. Whole-grain ready-to-eat oat cereal, as part of a dietary program for weight loss, reduces low-density lipoprotein cholesterol in adults with overweight and obesity more than a dietary program including low-fiber control foods.
Maki KC; Beiseigel JM; Jonnalagadda SS; Gugger CK; Reeves MS; Farmer MV; Kaden VN; Rains TM
J Am Diet Assoc; 2010 Feb; 110(2):205-14. PubMed ID: 20102847
[TBL] [Abstract][Full Text] [Related]
18. The association of dietary phytochemical index and cardiometabolic risk factors in adults: Tehran Lipid and Glucose Study.
Bahadoran Z; Golzarand M; Mirmiran P; Saadati N; Azizi F
J Hum Nutr Diet; 2013 Jul; 26 Suppl 1():145-53. PubMed ID: 23581519
[TBL] [Abstract][Full Text] [Related]
19. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
[TBL] [Abstract][Full Text] [Related]
20. Oral L-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass.
Lucotti P; Monti L; Setola E; La Canna G; Castiglioni A; Rossodivita A; Pala MG; Formica F; Paolini G; Catapano AL; Bosi E; Alfieri O; Piatti P
Metabolism; 2009 Sep; 58(9):1270-6. PubMed ID: 19592054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
